Emmaus Life Sciences, Inc. announced on October 2, 2023, the Board of Directors of company appointed George Sekulich to fill a vacancy on the Board of Directors created when Yutaka Niihara, M.D., M.P.H., the former Chairman and Chief Executive Officer, resigned as a director effective September 25, 2023. Mr. Sekulich, age 58, was recently appointed as Co-President and Chief Commercial Officer of the company and has served as Senior Vice President of Global Commercialization and Chief Information Officer since July 2019. From September 2014 through July 2019, Mr. Sekulich served as Chief Information Officer of EMI Holdings, Inc. (formerly, Emmaus Life Sciences, Inc.), wholly owned subsidiary.

Also on October 2, 2023, the Board of Directors appointed Willis Lee, the Co-President and Chief Operating Officer, to serve as Chairman of the Board of Directors.